Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The IsraelIRLCF -13.45%65 EV-to-EBIT is 12.62 as of Jul. 20, 2026, which is 30% above its 10-year median of 9.68. GuruFocus rates IRLCF with a GF Score™ of 65/100 and a GF Value™ of $273.43. The stock has 5 warning signs investors should review. Among 1,237 Chemicals companies, The Israel ranks better than 65.48% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
The Israel's Enterprise Value for the quarter that ended in Mar. 2026 was $8,085 Mil.
The Israel's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $653 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Israel EV-to-EBIT Related Terms
The Israel EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for The Israel's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, The Israel's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Israel EV-to-EBIT vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, The Israel's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where The Israel's EV-to-EBIT falls into.
The Israel's current Enterprise Value is $8,242 Mil.
The Israel's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $653 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Israel (IRLCF) has a EV-to-EBIT of 12.62 as of Jul. 20, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on The Israel and its competitors. This is 30% above median its historical median of 9.68. According to the industry distribution chart, The Israel ranks #427 out of 1237 companies in the Chemicals industry, placing it in the top 34.5%.
Is The Israel's EV-to-EBIT too high?
The Israel's current EV-to-EBIT of 12.62 is 30% above median its 10-year median of 9.68. The Chemicals industry median EV-to-EBIT is 17.36. The Israel's value of 12.62 is 27.3% below this industry median. Based on the distribution chart, The Israel ranks #427 out of 1237 companies in the Chemicals industry, which is above the industry midpoint. Overall, The Israel has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does The Israel's EV-to-EBIT compare to LIN and SHW?
According to the Chemicals industry distribution chart, The Israel ranks #427 out of 1237 companies for EV-to-EBIT. This puts The Israel in the upper half of its industry. The industry median EV-to-EBIT is 17.36. The Israel's value of 12.62 is 27.3% below this benchmark. While the company's 10-year median is 9.68 vs. the industry median of 17.36, The Israel has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Chemicals company?
The median EV-to-EBIT among Chemicals companies is 17.36, based on 1,237 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Israel's current EV-to-EBIT of 12.62 is 27.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on The Israel and its competitors. For the Chemicals industry, the median EV-to-EBIT is 17.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Israel's current EV-to-EBIT is 12.62, which is 30% above median its own 10-year median of 9.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Israel stock overvalued right now?
The Israel (IRLCF) has a current EV-to-EBIT of 12.62. The stock's GF Value™ is $273.43, compared to a current price of $238.00 — trading 13% below its estimated fair value. The current EV-to-EBIT is 12.62, which is 30% above median its 10-year median of 9.68 and 27.3% below the Chemicals industry median of 17.36. The Israel's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For The Israel (IRLCF), the current EV-to-EBIT is 12.62 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Israel (IRLCF) Overvalued in 2026?
Based on GuruFocus' analysis, The Israel stock appears to be undervalued.
The current stock price of $238.00 is trading 13% below its estimated GF Value™ of $273.43.
Key valuation signals for IRLCF:
EV-to-EBIT: 12.62 (30% above median its 10-year median of 9.68)
GF Value™: $273.43 vs. price of $238.00 (13% below fair value)
Industry Position: 27.3% below the Chemicals median (#427 of 1237)
No single metric tells the full story. See the IRLCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Israel Corp Ltd is a holding company. Along with its subsidiaries, it operates as a specialty minerals and chemicals company creating solutions to challenges in the food, agriculture, and industrial markets by leveraging its bromine, potash, and phosphate resources. The group operates through the following segments: Industrial Products (Bromine), Potash, Phosphate Solutions, and Growing Solutions. Maximum revenue is generated from its Phosphate Solutions segment, which manufactures phosphoric acid, sulphuric acid, green phosphoric acid, and phosphate fertilizers through its mines and facilities in Israel and China. Geographically, the group generates maximum revenue from Israel, followed by Europe, South America, North America, Asia, and other regions.
65GF Score
Get the complete analysis for IRLCF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IRLCF has been successfully added to your 
